Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × Histocompatibility Testing × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Pancreatic Neoplasms 4 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Rectal Neoplasms 1 Pancreatitis 1 Pancreatic Diseases 1 Neoplasms, Germ Cell and Embryonal 1 Medulloblastoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Epilepsy 1 Ependymoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Lobular 1 Bone Neoplasms 1

Interventions

Carboplatin 283 Cisplatin 209 Radiotherapy 184 Paclitaxel 169 Pemetrexed 156 Docetaxel 144 Gemcitabine 133 pembrolizumab 123 Erlotinib Hydrochloride 93 Magnetic Resonance Spectroscopy 89 Etoposide 83 Bevacizumab 75 Specimen Handling 71 Radiosurgery 64 durvalumab 63 Nivolumab 63 Vinorelbine 49 Blood Specimen Collection 48 osimertinib 47 Drug Therapy 46 Gefitinib 40 Surveys and Questionnaires 38 atezolizumab 37 Irinotecan 36 Biopsy 36 Topotecan 35 Radiation 35 Cyclophosphamide 34 Standard of Care 33 Surgical Procedures, Operative 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05092009 2025-07-15

IPON-3

Maastricht Radiation Oncology

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡